Silverman E.K. Mosley J.D. Palmer L.J. et al.

Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes.

Hum Mol Genet. 11: 623-632Denham S. Koppelman G.H. Blakey J. et al.

Meta-analysis of genome-wide linkage studies of asthma and related traits.

Respir Res. 9: 38Hersh C.P. Demeo D.L. Lange C. et al.

Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.

Am J Respir Cell Mol Biol. 33: 71-78Hirschhorn J.N. Altshuler D.

Once and again-issues surrounding replication in genetic association studies.

J Clin Endocrinol Metab. 87: 4438-4441Visscher P.M. Wray N.R. Zhang Q. et al.

10 Years of GWAS DISCOVERY: biology, function, and translation.

Am J Hum Genet. 101: 5-22Hersh C.P. Adcock I.M. Celedon J.C. et al.

High-throughput sequencing in respiratory, critical care, and sleep medicine research. an official american thoracic society workshop report.

Ann Am Thorac Soc. 16: 1-16Silverman E.K. Loscalzo J.

Network medicine approaches to the genetics of complex diseases.

Discov Med. 14: 143-152

Integrative genomics of chronic obstructive pulmonary disease.

Biochem Biophys Res Commun. 452: 276-286Moffatt M.F. Kabesch M. Liang L. et al.

Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma.

Nature. 448: 470-473Bansal M. Garg M. Agrawal A.

Advances in asthma genetics.

Adv Genet. 107: 1-32Moffatt M.F. Gut I.G. Demenais F. et al.

A large-scale, consortium-based genomewide association study of asthma.

N Engl J Med. 363: 1211-1221

What makes UK Biobank special?.

Lancet. 379: 1173-1174Ferreira M.A.R. Mathur R. Vonk J.M. et al.

Genetic architectures of childhood- and adult-onset asthma are partly distinct.

Am J Hum Genet. 104: 665-684Pividori M. Schoettler N. Nicolae D.L. et al.

Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.

Lancet Respir Med. 7: 509-522Johansson A. Rask-Andersen M. Karlsson T. et al.

Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema.

Hum Mol Genet. 28: 4022-4041Valette K. Li Z. Bon-Baret V. et al.

Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank.

Commun Biol. 4: 700Han Y. Jia Q. Jahani P.S. et al.

Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma.

Nat Commun. 11: 1776Demenais F. Margaritte-Jeannin P. Barnes K.C. et al.

Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks.

Nat Genet. 50: 42-53Tsuo K. Zhou W. Wang Y. et al.

Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity.

medRxiv. 2021.2011.2030.21267108Pillai S.G. Ge D. Zhu G. et al.

A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci.

PLoS Genet. 5: e1000421Wilk J.B. Chen T.H. Gottlieb D.J. et al.

A genome-wide association study of pulmonary function measures in the Framingham Heart Study.

PLoS Genet. 5: e1000429Hancock D.B. Eijgelsheim M. Wilk J.B. et al.

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function.

Nat Genet. 42: 45-52Repapi E. Sayers I. Wain L.V. et al.

Genome-wide association study identifies five loci associated with lung function.

Nat Genet. 42: 36-44Cho M.H. McDonald M.L. Zhou X. et al.

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.

Lancet Respir Med. 2: 214-225Hobbs B.D. de Jong K. Lamontagne M. et al.

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.

Nat Genet. 49: 426-432Sakornsakolpat P. Prokopenko D. Lamontagne M. et al.

Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations.

Nat Genet. 51: 494-505

The host factor in bronchitis.

Bronchitis Int Symp. Smolonska J. Koppelman G.H. Wijmenga C. et al.

Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.

Eur Respir J. 44: 860-872Pickrell J.K. Berisa T. Liu J.Z. et al.

Detection and interpretation of shared genetic influences on 42 human traits.

Nat Genet. 48: 709-717Hardin M. Cho M. McDonald M.L. et al.

The clinical and genetic features of COPD-asthma overlap syndrome.

Eur Respir J. 44: 341-350Hardin M. Silverman E.K. Barr R.G. et al.

The clinical features of the overlap between COPD and asthma.

Respir Res. 12: 127Kottyan L.C. Collier A.R. Cao K.H. et al.

Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner.

Blood. 114: 2774-2782Hersh C.P. Silverman E.K. Gascon J. et al.

SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development.

Am J Respir Crit Care Med. 183: 1482-1489Park S.Y. Jung H. Kim J.H. et al.

Longitudinal analysis to better characterize Asthma-COPD overlap syndrome: Findings from an adult asthma cohort in Korea (COREA).

Clin Exp Allergy. 49: 603-614John C. Guyatt A.L. Shrine N. et al.

Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap.

Chest. ()Olson J.E. Ryu E. Johnson K.J. et al.

The Mayo Clinic Biobank: a building block for individualized medicine.

Mayo Clin Proc. 88: 952-962

The Genotype-Tissue Expression (GTEx) project.

Nat Genet. 45: 580-585Chetwynd A.J. Dunn W.B. Rodriguez-Blanco G.

Collection and preparation of clinical samples for metabolomics.

Adv Exp Med Biol. 965: 19-44Christenson S.A. Steiling K. van den Berge M. et al.

Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 191: 758-766Woodruff P.G. Boushey H.A. Dolganov G.M. et al.

Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids.

Proc Natl Acad Sci U S A. 104: 15858-15863van den Berge M. Steiling K. Timens W. et al.

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity.

Thorax. 69: 14-23Saferali A. Yun J.H. Lee S. et al.

Transcriptomic signature of asthma-chronic obstructive pulmonary disease overlap in whole blood.

Am J Respir Cell Mol Biol. 64: 268-271Nayak A.P. Shah S.D. Michael J.V. et al.

Bitter taste receptors for asthma therapeutics.

Front Physiol. 10: 884

MicroRNAs: genomics, biogenesis, mechanism, and function.

Cell. 116: 281-297Pritchard C.C. Cheng H.H. Tewari M.

MicroRNA profiling: approaches and considerations.

Nat Rev Genet. 13: 358-369Alipoor S.D. Adcock I.M. Garssen J. et al.

The roles of miRNAs as potential biomarkers in lung diseases.

Eur J Pharmacol. 791: 395-404Hirai K. Shirai T. Shimoshikiryo T. et al.

Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap.

Allergy. 76: 766-774Gao J. Iwamoto H. Koskela J. et al.

Characterization of sputum biomarkers for asthma-COPD overlap syndrome.

Int J Chron Obstruct Pulmon Dis. 11: 2457-2465de Llano L.P. Cosio B.G. Iglesias A. et al.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

Int J Chron Obstruct Pulmon Dis. 13: 591-601Kominsky D.J. Campbell E.L. Colgan S.P.

Metabolic shifts in immunity and inflammation.

J Immunol. 184: 4062-4068

The concept of airway inflammation.

Am J Respir Crit Care Med. 162: S2-S6Ghosh N. Choudhury P. Kaushik S.R. et al.

Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).

Respir Res. 21: 126

Principles and challenges of genomewide DNA methylation analysis.

Nat Rev Genet. 11: 191-203Edris A. den Dekker H.T. Melen E. et al.

Epigenome-wide association studies in asthma: a systematic review.

Clin Exp Allergy. 49: 953-968Qiu W. Baccarelli A. Carey V.J. et al.

Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.

Am J Respir Crit Care Med. 185: 373-381Chen Y.C. Tsai Y.H. Wang C.C. et al.

Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes.

Sci Rep. 11: 5022Shrine N. Guyatt A.L. Erzurumluoglu A.M. et al.

New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries.

Nat Genet. 51: 481-493Yengo L. Sidorenko J. Kemper K.E. et al.

Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry.

Hum Mol Genet. 27: 3641-3649Tashkin D.P. Altose M.D. Connett J.E. et al.

Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Am J Respir Crit Care Med. 153: 1802-1811Hansel N.N. Pare P.D. Rafaels N. et al.

Genome-wide association study identification of novel loci associated with airway responsiveness in chronic obstructive pulmonary disease.

Am J Respir Cell Mol Biol. 53: 226-234Hao K. Bosse Y. Nickle D.C. et al.

Lung eQTLs to help reveal the molecular underpinnings of asthma.

PLoS Genet. 8: e1003029Yun J.H. Lamb A. Chase R. et al.

Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.

J Allergy Clin Immunol. 141: 2037-2047 e2010Yun J.H. Chase R. Parker M.M. et al.

Peripheral blood gene expression signatures of eosinophilic chronic obstructive pulmonary disease.

Am J Respir Cell Mol Biol. 61: 398-401Choy D.F. Jia G. Abbas A.R. et al.

Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma.

J Allergy Clin Immunol. 138: 1230-1233 e1238Barnig C. Alsaleh G. Jung N. et al.

Circulating human eosinophils share a similar transcriptional profile in asthma and other hypereosinophilic disorders.

PLoS One. 10: e0141740Sridhar S. Liu H. Pham T.H. et al.

Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.

Respir Res. 20: 14Asensio V.J. Tomas A. Iglesias A. et al.

Eosinophilic COPD patients display a distinctive serum miRNA profile from asthma and non-eosinophilic COPD.

Arch Bronconeumol (Engl Ed). 56: 234-241Hersh C.P. Zacharia S. Prakash Arivu Chelvan R. et al.

Immunoglobulin E as a biomarker for the overlap of atopic asthma and chronic obstructive pulmonary disease.

Chronic Obstr Pulm Dis. 7: 1-12Portelli M.A. Dijk F.N. Ketelaar M.E. et al.

Phenotypic and functional translation of IL1RL1 locus polymorphisms in lung tissue and asthmatic airway epithelium.

JCI Insight. 5: e132446Granada M. Wilk J.B. Tuzova M. et al.

A genome-wide association study of plasma total IgE concentrations in the framingham heart study.

J Allergy Clin Immunol. 129: 840-845 e821Astle W.J. Elding H. Jiang T. et al.

The allelic landscape of human blood cell trait variation and links to common complex disease.

Cell. 167: 1415-1429 e1419Chen M.H. Raffield L.M. Mousas A. et al.

Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations.

Cell. 182: 1198-1213 e1114Taliun D. Harris D.N. Kessler M.D. et al.

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program.

Nature. 590: 290-299Daya M. Cox C. Acevedo N. et al.

Multiethnic genome-wide and HLA association study of total serum IgE level.

J Allergy Clin Immunol. 148: 1589-1595Mikhaylova A.V. McHugh C.P. Polfus L.M. et al.

Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: the NHLBI TOPMed program.

Am J Hum Genet. 108: 1836-1851

Precision medicine--personalized, problematic, and promising.

N Engl J Med. 372: 2229-2234Martin A.R. Kanai M. Kamatani Y. et al.

Clinical use of current polygenic risk scores may exacerbate health disparities.

Nat Genet. 51: 584-591Fatumo S. Chikowore T. Choudhury A. et al.

A roadmap to increase diversity in genomic studies.

Nat Med. 28: 243-250Sandhaus R.A. Turino G. Brantly M.L. et al.

The diagnosis and management of alpha-1 antitrypsin deficiency in the adult.

Chronic Obstr Pulm Dis. 3: 668-682Miravitlles M. Dirksen A. Ferrarotti I. et al.

European respiratory society statement: diagnosis and treatment of pulmonary disease in alpha1-antitrypsin deficiency.

Eur Respir J. 50: 1700610